A new pancreatic cancer pill called daraxonrasib nearly doubled survival in a 500-person Phase 3 trial
The post The Pancreatic Cancer Pill That Made Oncologists Stand Up and Cheer appeared first on The Hearty Soul.
A new pancreatic cancer pill called daraxonrasib nearly doubled survival in a 500-person Phase 3 trial
The post The Pancreatic Cancer Pill That Made Oncologists Stand Up and Cheer appeared first on The Hearty Soul.